Avaliação fenotípica e funcional dos linfócitos T citotóxicos de indivíduos infectados pelo HTLV-1 com diagnóstico de HAM/TSP / Phenotypic and functional assessment of cytotoxic T lymphocytes from individuals infected with HTLV-1 diagnosed with HAM / TSP

O Brasil representa uma das áreas endêmicas para o vírus linfotrópico de células T humanas do tipo 1 (HTLV-1) e a cidade de Salvador, Bahia, possui a maior prevalência nacional da infecção por este retrovírus (1,8%), com cerca de 50.000 pessoas infectadas. O HTLV-1 foi o primeiro retrovírus humano descrito e está classicamente associado à leucemia/linfoma de células T do adulto (ATLL) e à mielopatia associada ao HTLV-1/paraparesia espástica tropical (HAM/TSP). A HAM/TSP é uma doença inflamatória do sistema nervoso central, cujos mecanismos imunopatogênicos não estão completamente elucidados. O papel dos linfócitos T citotóxicos na patogênese desta doença ainda não está bem definido. Neste estudo, foram avaliados o fenótipo e a função de linfócitos T citotóxicos de pacientes infectados pelo HTLV-1 com HAM/TSP...

Brazil represents one of the largest endemic areas for human T-lymphotropic virus cells type 1 (HTLV-1) infection and associated diseases. Salvador, Bahia, is considered as the Brazilian city with the highest national HTLV-1prevalence (around 1.8% in the general population). HTLV -1 was the first human retrovirus described and is classically associated with adult Tcell leukemia/lymphoma (ATLL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/TSP is a chronic and progressive inflammatory disease of the central nervous system and your immunopathogenic mechanisms are not completely understood. The role of cytotoxic T-lymphocytes (CTLs) in the pathogenesis of this disease is still undefined. In this study we evaluated the phenotype and function of cytotoxic Tlymphocytes from HTLV-1-infected patients with HAM/TSP...

Non Hodgkin T cell lymphoma: an atypical clinical presentation / Linfoma não Hodgkin de células T citotóxico: uma apresentação clínica atípica

Cytotoxic lymphomas comprise a spectrum of peripheral T-cell lymphomas that can have a initial or late cutaneous presentation. We describe a 46-year-old man from Cape Verde, with a dermatosis involving his face and trunk, consisting of monomorphic papules with a smooth surface and both motor and sensory polyneuropathy.The hypothesis of leprosy was supported by the clinical and initial hystopathological findings and the patient was referred to our hospital with suspected Hansen's disease. In the new skin and lymph node biopsies a lymphocyte population was identified whose immunohystochemistry study allowed the diagnosis of T-cell lymphoma with expression of cytotoxic markers. The patient was started on chemotherapy with initial remission of the skin lesions but, subsequently, progression of systemic disease.

Os linfomas citotóxicos compreendem um espectro de linfomas de células T periféricos e linfomas Natural Killer que podem ter expressão cutânea primária ou secundária. Descrevemos o caso de um homem com 46 anos de idade, natural de Cabo Verde,com dermatose envolvendo a face e tronco constituída por pápulas monomorfas superfície lisa e polineuropatia sensitivo motora.A hipótese de Hanseníase foi colocada suportada por achados histopatológicos sugestivos sendo o doente referenciado à consulta de Doença de Hansen do nosso hospital. Em biopsia de pele e de gânglio identificou-se proliferação linfocitária cujo estudo imunohistoquímico permitiu o diagnóstico de linfoma T com expressão de marcadores citotóxicos. Iniciou quimioterapia verificando-se inicialmente remissão parcial das lesões cutâneas mas posteriormente a progressão da doença sistémica.

Linfoma primario cutáneo agresivo epidermotrópico de células T citotóxicas CD8 positivo: Caso clínico / Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: Report of one case

Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma, is an uncommon disease, with an aggressive clinical behavior. Differentiation with other types of cutaneous T-cell lymphoma (CTCL) that express a CD8+ cells, is based only on clinical grounds and in certain morphological characteristics, such as a marked epidermotropism with squamous cell necrosis. We report a 50-year-old male presenting with painless cutaneous lesions appearing in trunk, limbs, scalp and face, suggestive of cutaneous lymphoma. He was admitted to the hospital in bad conditions, with confluent papules and tumors, some of them ulcerated and with foul smelling honey-colored crusts, involving the complete body surface. Cutaneous biopsy demonstrated a CD8 positive epidermotropic cytotoxic T cell lymphoma. He was treated with chemotherapy with an excellent initial response, but cutaneous lesions reappeared after four cycles. He did not respond to rescue chemotherapy and died seven months after diagnosis.

Expression of cancer-testis associated antigen MAGE-1 in relation to CD8+ T lymphocytes in breast infiltrating duct carcinoma [NOS]

Breast cancers are known to frequently [over] express several well-characterized tumor-associated antigens [TAAs] such as members of the MAGE-family. In the present study we are aiming to evaluate MAGE-1 expression in breast infiltrating duct carcinoma [NOS] in relation to some other known prognostic factors. We will compare this with MAGE-1 expression in some of the benign breast tumors and tumor-like lesions. We are also aiming to study the relation between MAGE-1 expression and lymphocytic response specifically CD8+ T lymphocytes as a hope for further breast cancer immunotherapy. After obtaining informed consent, tissues were obtained from patients undergoing breast lumpectomy or mastectomy. 132 patients of breast infiltrating duct carcinoma [IDC] [NOS] and 65 benign breast lesions were enrolled in this study. The cases were evaluated clinically by the surgeon and physician and any other information was added from the accompanying clinical data. All cases were studied by the histopathologist and immunostain was done for MAGE-1 and CDS. The malignant cases were additionally stained by estrogjenj-eceptors, progesterone receptors and Her-2 as a prognostic markers. The results were statistically studied and tabulated. In the present study we classified the patients into two groups. Group I: Include patients with breast carcinomas of IDC [NOS] type and group II: Include patients with benign breast lesions. The total number of cases was 197, 35 were males while 162 were females. Age ranged between 18-88.132 of the cases were with IDC [NOS] and 65 were with benign breast lesions. There was a significant difference in V1AGE-1 expression between the both groups, it was more expressed in group I and there was a highly significant relation between MAGE-1 expression in IDC [NOS] and the score of CD8+lymphocytes. On the other hand the relation between MAGE-1 and CD8+ lymphocytes was not significant in group II. In fibrocytic disease [FCD], MAGE was +2 in most of FCD cases and CD8+ lymphocytes scored +4 in four cases, but still the relation between the both variables non significant. We have demonstrated in the present study that MAGE-1 is expressed in some of benign breast lesions and at a high proportion in high-grade, hormone receptor-negative breast cancer, suggesting that MAGE-1 could be an indicator of aggressive diseases and can be a promising tumor antigen for immunotherapy of breast cancer with poor prognosis. On the other hand we suggest further studies to evaluate the rule of MAGE-1 vaccine in benign breast lesions as a preventive therapy

Distribution of CD8 and CD20 lymphocytes in chronic periapical inflammatory lesions

O objetivo deste estudo foi o de investigar a distribuição de linfócitos CD8+ e CD20+ em lesões inflamatórias periapicais. Para tanto foram estudados 90 casos entre abscessos crônicos, cistos abscedados e cistos inflamatórios. A tecnica de imunohistoquímica pelo método da estreptavidina-biotina foi utilizada para identificar linfócitos T citotóxico/supressor (CD8) e linfócito B (CD20). Dentre os resultados encontrados notou-se uma distribuição das células CD8+ da seguinte forma: 1) difusa na capsula fibrosa dos abscessos crônicos (58,8 por cento) e ausente nos cistos abscedados (64,1 por cento) e cistos inflamatórios (70,6 por cento); 2) zona infiltrativa: difusa nos cistos abscedados (100 por cento) e cistos inflamatórios (82,4 por cento); 3) zona subepitelial: ausente nos cistos inflamatórios (53,0 por cento) e difusa nos cistos abscedados (56,4 por cento); 4) zona de supuração: difusa nos abscessos crônicos (100 por cento) e cistos abscedados (97,5 por cento). As células CD20+ apresentavam a seguinte distribuição: 1) cápsula fibrosa: ausente nos cistos inflamatórios (100 por cento), cistos abscedados (94,8 por cento) e abscessos crônicos (88,3 por cento); 2) zona infiltrativa: difusa nos cistos abscedados (100 por cento) e cistos inflamatórios (53 por cento); 3) zona subepitelial: ausente nos cistos inflamatórios (58,8 por cento) e focal nos cistos abscedados (46,2 por cento); 4) zona de supuração: difusa nos cistos abscedados (100 por cento) e abscessos crônicos (100 por cento). Em conclusão é possível afirmar que a distribuição linfocitária é predominantemente difusa para ambos os tipos de linfócitos.